Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis

.


from Cancer via ola Kala on Inoreader http://ift.tt/2rlmkLh
via IFTTT